Francis Burrows - 02 Jan 2025 Form 3 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Scientific Officer
Signature
Teresa Bair, Attorney-in-fact for Francis Burrows
Issuer symbol
KURA
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
3
Filing time
07 Jan 2025, 17:25:53 UTC
Next filing
28 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KURA Common Stock 22,871 02 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 60,000 $14.00 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 5,000 $4.80 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 30,000 $4.80 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 30,000 $6.15 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 15,000 $20.00 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 27,500 $15.47 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 26,565 $11.86 Direct F2
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 25,000 $32.80 Direct F3
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 25,000 $14.15 Direct F4
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 85,000 $11.99 Direct F5
holding KURA Option to purchase common stock 02 Jan 2025 Common Stock 85,000 $15.36 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 14,621 shares of common stock and 8,250 shares of common stock that may be issued pursuant to the following restricted stock unit awards (RSUs): (i) 2,000 shares pursuant to a RSU granted on 1/26/21 that will vest on 1/26/25, and (ii) 6,250 shares pursuant to a RSU granted on 1/26/22 that will vest in equal installments on 1/26/25 and 1/26/26.
F2 Fully Vested
F3 This option vests in 48 equal monthly installments commencing on the grant date of 1/26/21.
F4 This option vests in 48 equal monthly installments commencing on the grant date of 1/26/22.
F5 This option vests in 48 equal monthly installments commencing on the grant date of 2/16/23.
F6 This option vests in 48 equal monthly installments commencing on the grant date of 1/2/24.